International Journal of Medical Sciences · 2020 · 50 citations · 28 references
MedicineMolecular MedicineOncologyMolecular DiagnosticsMolecular OncologyNeoplasiaCancer BiomarkersCancer Molecular DiagnosticsExosome AnalysisLung CancerMicrorna BiologyNext-generation Sequencing In OncologyCirculating MicrornasCirculating Rna BiomarkersDiagnostic BiomarkersExosomal BiomarkersLung AdenocarcinomaMicrorna BiomarkersMicrorna Prognostic MarkersPrognostic Tumor Markers
Lung cancer has been the leading cause of cancer morbidity and mortality in recent years. Most lung cancers are often asymptomatic until advanced or metastatic stage. Therefore, looking for the diagnostic biomarker for early-stage lung cancer is quite significant. Circulating exosomal microRNAs (miRNAs) have been reported to be the diagnostic and prognostic markers of various cancers. Here, we obtained circulating exosomal miRNA repertoires of 7 early-stage lung adenocarcinoma patients including pre-operation and post-operation (LA-pre and LA-post) and 7 heathy controls (HCs) by next generation sequence (NGS) and selected miR-342-5p, miR-574-5p and miR-222-3p to validate in ampliative samples by reverse transcription-quantitative PCR (RT-qPCR). Circulating exosomal miR-342-5p, miR-574-5p and miR-222-3p not only significantly elevated in LA patients (n = 56) compared with HCs (n = 40), but also significantly decreased after tumor resection when analyzed 51 paired pre- and post-operation samples. Furthermore, miR-342-5p and miR-574-5p, but not miR-222-3p, had a significantly elevated expression level in carcinoma tissue compared with adjacent non-cancerous tissue (n = 8). The receiver operating characteristic (ROC) curve showed the area under the curve (AUC) of combined miR-342-5p and miR-574-5p was 0.813 (95% CI: 0.7249 to 0.9009) with sensitivity and specificity of 80.0% and 73.2% respectively. In summary, circulating exosomal miR-342-5p and miR-574-5p have potential to serve as novel diagnostic biomarkers for early-stage LA.
28
Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship
Julian R. Molina, Ping Yang, Stephen D. Cassivi et al. · Mayo Clinic Proceedings · 2008 · 2.9K citations
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Sónia A. Melo, Linda B. Luecke, Christoph Kahlert et al. · Nature · 2015 · 2.9K citations · Full text
miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs
Fuliang Xie, Peng Xiao, Dongliang Chen et al. · Plant Molecular Biology · 2012 · 1.6K citations